Novel Coronavirus (SARS-CoV-2/COVID-19)
The Food and Drug Administration yesterday updated the health care provider fact sheets for all three monoclonal antibody therapies authorized for emergency use to include information on whether SARS-CoV-2 variants may show resistance to that therapy.
AHA urged the Centers for Medicare & Medicaid Services to extend the five-year window for building medical residency programs to account for the COVID-19 public health emergency.
As part of AHA鈥檚 Joining Hands for Greater Impact series, we talk to Atrium Health, American Airlines and Charlotte Douglas International Airport representatives about how they came together to 鈥済et shots in arms鈥 in Charlotte, N.C.
AHA鈥檚 Living Learning Network open house event will feature insight from UCLA Health leaders on successful strategies and creative solutions being used to efficiently and equitably accelerate the COVID-19 vaccine rollout, as well as lessons learned along the way. As marginalized populations have鈥
Recorded March 30, 2021
12-1 p.m. ET
The incredible job that hospitals and caregivers have done over the past year saving lives, treating very sick patients and protecting their communities has been acknowledged and enabled by Congress through relief aid several times since the onset of the COVID-19 pandemic.
H-ISAC TLP Green Coronavirus Daily Update for March 19, 2021.
The major Headlines, US Snapshots, US Vaccinations, US Variant Cases, key Highlights, as well as key Statistics, Vaccine and Treatment information, US Restrictions and the Back to Normal Index related to the novel coronavirus pandemic.
For the first time, the Food and Drug Administration authorized marketing a SARS-CoV-2 diagnostic test beyond the public health emergency based on additional data. FDA previously authorized the BioFire Respiratory Panel 2.1 test for emergency use to detect SARS-CoV-2 and other respiratory pathogens鈥
The Centers for Disease Control and Prevention has created a federal classification scheme for SARS-CoV-2 variants and posted information on their prevalence in the United States.